Learn everything you need to know about Candesartan-pronunciation, uses, dosage guidelines, indications, and when to take or avoid it. Get up-to-date information on side effects, precautions, warnings ...
Are you taking Candesartan? Are you aware of the dangers of combining Candesartan with certain foods, herbs, or alcohol? Drug-food-interactions are seldom discussed but can lead to undesirable side ...
BOSTON — The angiotensin receptor blocker candesartan (Atacand, AstraZeneca Pharmaceuticals LP) is safe and as effective as the beta blocker propranolol in preventing migraine headaches, according to ...
Please provide your email address to receive an email when new articles are posted on . Researchers analyzed medical records of 50 adolescents treated at Texas Children’s Hospital Headache Clinic.
Objective: The aim of this study was to compare the antihypertensive efficacy and tolerability of the calcium channel antagonist amlodipine besylate versus the angiotensin II type 1 receptor ...
The angiotensin receptor blocker (ARB) candesartan had cognitive benefits that were likely independent of the drug's blood pressure (BP)-lowering effect, a small randomized trial indicated. People ...
A blood pressure drug offers hope to migraine sufferers who currently get no relief from existing treatments. Candesartan is just as effective as more the commonly prescribed propranolol when it comes ...
Taking a much higher than recommended dose of the hypertension drug candesartan cilexetil effectively lowered the amount of protein excreted in the urine of patients with kidney disease, according to ...
HAIKOU, China, Aug. 5, 2021 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that its ...
Prehypertension is considered a precursor of stage 1 hypertension and a predictor of excessive cardiovascular risk. We investigated whether pharmacologic treatment of prehypertension prevents or ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results